Nephros Future Growth

Future criteria checks 4/6

Nephros is forecast to grow earnings and revenue by 128.2% and 10.1% per annum respectively while EPS is expected to grow by 122.8% per annum.

Key information

128.2%

Earnings growth rate

122.8%

EPS growth rate

Machinery earnings growth9.5%
Revenue growth rate10.1%
Future return on equityn/a
Analyst coverage

Low

Last updated11 Nov 2024

Recent future growth updates

Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

May 13
Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

Recent updates

It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)

Oct 03
It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)

We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn

Jul 14
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn

Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

May 13
Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar

Dec 18
After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar

At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?

Dec 14
At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?

Nephros partners with Donastar and Tractor Beverage to supply and service nationwide fast-casual restaurant operation

Sep 28

US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results

Aug 13
US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results

Market Sentiment Around Loss-Making Nephros, Inc. (NASDAQ:NEPH)

Mar 25
Market Sentiment Around Loss-Making Nephros, Inc. (NASDAQ:NEPH)

At US$8.37, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?

Mar 04
At US$8.37, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?

Announcing: Nephros (NASDAQ:NEPH) Stock Increased An Energizing 131% In The Last Five Years

Jan 28
Announcing: Nephros (NASDAQ:NEPH) Stock Increased An Energizing 131% In The Last Five Years

Nephros sees Q4 revenue in-line with estimates,

Jan 12

Nephros, Inc. (NASDAQ:NEPH) Insiders Increased Their Holdings

Dec 08
Nephros, Inc. (NASDAQ:NEPH) Insiders Increased Their Holdings

Nephros EPS beats by $0.02, misses on revenue

Nov 05

Earnings and Revenue Growth Forecasts

NasdaqCM:NEPH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026171N/AN/A1
12/31/2025150N/AN/A1
12/31/2024140N/AN/A2
9/30/202414-1-2-2N/A
6/30/202414-1-1-1N/A
3/31/202414-100N/A
12/31/202314-211N/A
9/30/202314-211N/A
6/30/202312-300N/A
3/31/202312-3-1-1N/A
12/31/202210-5-3-3N/A
9/30/202210-5-4-3N/A
6/30/202210-4-4-4N/A
3/31/202210-4-3-3N/A
12/31/202110-3-2-1N/A
9/30/202110-3-3-3N/A
6/30/20219-4-4-4N/A
3/31/20219-4-5-5N/A
12/31/20209-5-7-7N/A
9/30/20209-4-5-5N/A
6/30/202010-4-4-4N/A
3/31/202011-3-3-3N/A
12/31/201910-3-2-2N/A
9/30/20199-4-3-3N/A
6/30/20197-4-4-4N/A
3/31/20196-3-4-4N/A
12/31/20186-3-4-4N/A
9/30/20185-1-1-1N/A
6/30/20185-1N/A-1N/A
3/31/20184-2N/A0N/A
12/31/20174-1N/A0N/A
9/30/20173-3N/A-2N/A
6/30/20173-3N/A-2N/A
3/31/20172-3N/A-2N/A
12/31/20162-3N/A-2N/A
9/30/20162-3N/A-3N/A
6/30/20162-3N/A-3N/A
3/31/20162-4N/A-3N/A
12/31/20152-3N/A-4N/A
9/30/20152-3N/A-3N/A
6/30/201520N/A-3N/A
3/31/20152-4N/A-3N/A
12/31/20142-7N/A-2N/A
9/30/20142-2N/A-3N/A
6/30/20142-6N/A-2N/A
3/31/20142-1N/A-3N/A
12/31/201321N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NEPH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: NEPH is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NEPH is expected to become profitable in the next 3 years.

Revenue vs Market: NEPH's revenue (10.1% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: NEPH's revenue (10.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NEPH's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 18:06
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nephros, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company
Marc WiesenbergerB. Riley Securities, Inc.
Anthony VendettiMaxim Group